Emcure Pharmaceuticals has received a good response to its IPO, with shares trading at a premium of Rs 360 in the unlisted market. Based on the upper price ...

Emcure Pharmaceuticals' IPO has seen strong interest from investors, with the offer being nearly 68 times oversubscribed. The share allotment is expected to ...

Emcure Pharmaceuticals' IPO, which launched today, has seen 66% subscription so far, mainly due to strong interest from non-institutional investors (NII)....

The capital markets regulator, SEBI (Securities and Exchange Board of India), has approved the IPOs of Ola Electric and Emcure Pharmaceuticals. Both companies ...